These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11349387)

  • 1. Time-dependent actions of D2 family agonist quinpirole on spontaneous behavior in the rat: dissociation between sniffing and locomotion.
    Horvitz JC; Williams G; Joy R
    Psychopharmacology (Berl); 2001 Apr; 154(4):350-5. PubMed ID: 11349387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W; Neill DB; Lynn M; Justice JB
    Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats.
    Ushijima I; Carino MA; Horita A
    Pharmacol Biochem Behav; 1995 Dec; 52(4):737-41. PubMed ID: 8587913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats.
    Van Hartesveldt C
    Pharmacol Biochem Behav; 1997 Dec; 58(4):955-60. PubMed ID: 9408200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of D2 receptors with quinpirole and sulpiride affects locomotor activity before spatial behavior of rats in an active place avoidance task.
    Stuchlik A; Rehakova L; Rambousek L; Svoboda J; Vales K
    Neurosci Res; 2007 Jun; 58(2):133-9. PubMed ID: 17360063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2 receptor blockade in the dorsal raphe increases quinpirole-induced locomotor excitation.
    Szumlinski KK; Szechtman H
    Neuroreport; 2002 Apr; 13(5):563-6. PubMed ID: 11973446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
    Hooks MS; Jones DN; Holtzman SG; Juncos JL; Kalivas PW; Justice JB
    Psychopharmacology (Berl); 1994 Oct; 116(2):217-25. PubMed ID: 7862951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
    Cook CD; Newman JL; Winfree JC; Beardsley PM
    Pharmacol Biochem Behav; 2004 Feb; 77(2):309-18. PubMed ID: 14751459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats.
    Frantz KJ; Van Hartesveldt C
    Psychopharmacology (Berl); 1995 Jun; 119(3):299-304. PubMed ID: 7675965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole.
    Lomanowska A; Gormley S; Szechtman H
    Pharmacol Biochem Behav; 2004 Mar; 77(3):617-22. PubMed ID: 15006474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
    Johnson EF; Szechtman H
    Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The locomotor effects of a putative dopamine D3 receptor agonist in developing rats.
    Frantz K; Babcock D; Van Hartesveldt C
    Eur J Pharmacol; 1996 Apr; 302(1-3):1-6. PubMed ID: 8790984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze.
    Vorhees CV; Johnson HL; Burns LN; Williams MT
    Neurotoxicol Teratol; 2009; 31(1):1-10. PubMed ID: 18930132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral response profiles following drug challenge with dopamine receptor subtype agonists and antagonists in developing rat.
    Sobrian SK; Jones BL; Varghese S; Holson RR
    Neurotoxicol Teratol; 2003; 25(3):311-28. PubMed ID: 12757828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of biphasic locomotor effects of quinpirole.
    Van Hartesveldt C; Meyer ME; Potter TJ
    Pharmacol Biochem Behav; 1994 Jul; 48(3):781-6. PubMed ID: 7938135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The locomotor effects of quinpirole in rats depend on age and gender.
    Frantz KJ; Van Hartesveldt C
    Pharmacol Biochem Behav; 1999 Dec; 64(4):821-6. PubMed ID: 10593206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.